PROCEPT BioRobotics Corporation
NASDAQ:PRCTMedical - Devices
+$0.19 today
- Market cap
- $1.45B
- Beta
- 0.85
- P/E (TTM)
- -11.6
- EPS (TTM)
- -$1.81
Volume 2.05M
Average 1.46M
PRCT Tax Assets
Deferred tax assets that can reduce taxes payable in future periods.
PROCEPT BioRobotics CorporationNASDAQ: PRCT
Tax Assets · Q1 FY2026 · quarter ended Mar 2026
Tax assets remains negative
Q1 FY2026 tax assets was $0, compared with $0 a year earlier.
Context
- Tax assets amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Tax assets increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Tax Assets history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Tax Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Tax Assets vs competitors
How PRCT compares with its peers on the latest reported figures
- PRCT's Mar 2026 tax assets of $0 is the 3rd highest of the 5 companies compared; the peer median is $402.88K.
- Tax assets amounts to 0.0% of total assets for PRCT, versus a peer median of 0.4%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
FOCLEDAP TMS S.A. American Depositary Shares | Mar 2026 | $1.09M | — | +7.3% | 1.5% |
| Mar 2026 | $805.75K | — | — | 0.9% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding PRCT) | $402.88K | — | +7.3% | 0.4% | |
Competitors are the stored peer set for PRCT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 304.32M | 222.64M | 257.22M | 333.73M | 286.5M |
| Short-term Investments | 0 | 0 | 0 | 0 | 0 |
| Net Receivables | 4.46M | 15.27M | 48.38M | 83.5M | 83.53M |
| Inventory | 13.15M | 28.54M | 39.76M | 56.17M | 70.69M |
| Other Current Assets | 3.41M | 6.18M | 5.21M | 8.45M | 9.65M |
| Total Current Assets | 326.17M | 272.63M | 350.57M | 481.84M | 450.38M |
| Property, Plant & Equipment (Net) | 8.32M | 32.14M | 48.99M | 45.65M | 47.94M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 1.75M | 1.48M | 1.2M | 932K | 709K |
| Long-term Investments | 777K | 3.04M | 3.04M | 3.04M | 3.04M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 51K | 919K | 2.56M | 6.02M |
| Total Non-current Assets | 10.85M | 36.7M | 54.15M | 52.18M | 57.7M |
| Total Assets | 337.02M | 309.33M | 404.72M | 534.02M | 508.08M |
| Account Payables | 2.03M | 9.39M | 13.5M | 10.03M | 17.29M |
| Short-term Debt | 2.11M | 2.13M | 1.68M | 1.91M | 0 |
| Tax Payables | 515K | 829K | 1.73M | 2.07M | 0 |
| Deferred Revenue | 1.02M | 2.86M | 5.66M | 9.57M | 13.05M |
| Other Current Liabilities | 4.61M | 7.47M | 8.2M | 10.09M | 35.46M |
| Total Current Liabilities | 16.24M | 35.29M | 45.93M | 53.13M | 65.8M |
| Long-term Debt | 50M | 51.21M | 51.34M | 51.47M | 51.62M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 1.7M | 1.78M | 517K | 324K | 24.8M |
| Total Non-current Liabilities | 53.69M | 76.97M | 78.04M | 78.66M | 76.42M |
| Total Liabilities | 69.93M | 112.26M | 123.97M | 131.8M | 142.21M |
| Common Stock | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | (261.52M) | (348.68M) | (454.57M) | (545.99M) | (641.56M) |
| Accumulated OCI | (54K) | (6K) | 84K | 114K | 37K |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 267.09M | 197.07M | 280.75M | 402.22M | 365.87M |
| Total Debt | 54.1M | 77.32M | 79.2M | 80.25M | 51.62M |
| Net Debt | (250.22M) | (145.32M) | (178.02M) | (253.48M) | (234.89M) |
PROCEPT BioRobotics Corporation
NASDAQ:PRCT
Intrinsic Alpha fair value
Locked
Current Price
$25.18
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.